Abbott (ABT) slips as results, guidance barely meet consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Abbott (ABT) slips as results, guidance barely meet consensus

Abbott forecasts 2024 earnings largely below estimates, shares down

January 24, 2024 7:34 AM EST

(Reuters) -Abbott Laboratories on Wednesday forecast 2024 profit largely below Wall Street estimates despite meeting quarterly earnings expectations, sending the medical device maker's shares down 2.5% in premarket trading.

Expectations around performance of medical device makers have increased over the last one month after health insurers flagged higher medical costs earlier this month as people, especially older adults, go back for medical procedures they had delayed during the pandemic.

Abbott's forecast also follows strong... More

Abbott (ABT) Reports In-Line Q4 EPS, Offers Guidance

January 24, 2024 7:31 AM EST

Abbott (NYSE: ABT) reported Q4 EPS of $1.19, in-line with the analyst estimate of $1.19. Revenue for the quarter came in at $10.24 billion versus the consensus estimate of $10.17 billion.

GUIDANCE:

Abbott sees FY2024 EPS of $4.50-$4.70, versus the consensus of $4.63.

For earnings history and earnings-related data on Abbott (ABT) click here.

... More

Abbott Labs (ABT) PT Raised to $136 at UBS

January 22, 2024 7:52 AM EST

UBS analyst Danielle Antalffy raised the price target on Abbott Labs (NYSE: ABT) to $136.00 (from $122.00) while maintaining a Buy rating.... More